Lipid-bilayer coated nanosized bimodal mesoporous carbon spheres for controlled release applications

Highly mesoporous nanosized carbon spheres (MCS) equipped with an active lipid bilayer demonstrate pronounced molecular release behavior, and excellent potential for drug delivery applications. We report a facile synthesis route for the creation of colloidal MCS with a bimodal pore size distribution, featuring a high BET surface area combined with high pore volume. Bimodal mesoporosity was achieved by a simultaneous co-assembly of a polymer resin (resol), tetraethyl orthosilicate (TEOS) and a block copolymer (Pluronic F127). The spherical geometry originates from casting the precursor mixture into a macroporous silica hard template, having a mean pore size of 60 nm, followed by thermopolymerization and final carbonization at 900 °C in nitrogen atmosphere. The final bimodal mesoporous MCS were obtained after removal of inorganic compounds by etching with hydrofluoric acid. Colloidal suspensions of MCS were prepared by oxidation with ammonium persulfate. MCS were loaded with calcein as a model drug. Efficient sealing of the MCS was achieved with a supported lipid bilayer (SLB). The SLB acts as a diffusion barrier against the uncontrolled release of encapsulated dye molecules until the release is triggered via the addition of a surface active agent. The high surface area and pore volume and the excellent release characteristics make the SLB-coated MCS a promising release-on-demand system

Lipid-bilayer coated nanosized bimodal mesoporous carbon spheres for controlled release applications

Highly mesoporous nanosized carbon spheres (MCS) equipped with an active lipid bilayer demonstrate pronounced molecular release behavior, and excellent potential for drug delivery applications. We report a facile synthesis route for the creation of colloidal MCS with a bimodal pore size distribution, featuring a high BET surface area combined with high pore volume. Bimodal mesoporosity was achieved by a simultaneous co-assembly of a polymer resin (resol), tetraethyl orthosilicate (TEOS) and a block copolymer (Pluronic F127). The spherical geometry originates from casting the precursor mixture into a macroporous silica hard template, having a mean pore size of 60 nm, followed by thermopolymerization and final carbonization at 900 °C in nitrogen atmosphere. The final bimodal mesoporous MCS were obtained after removal of inorganic compounds by etching with hydrofluoric acid. Colloidal suspensions of MCS were prepared by oxidation with ammonium persulfate. MCS were loaded with calcein as a model drug. Efficient sealing of the MCS was achieved with a supported lipid bilayer (SLB). The SLB acts as a diffusion barrier against the uncontrolled release of encapsulated dye molecules until the release is triggered via the addition of a surface active agent. The high surface area and pore volume and the excellent release characteristics make the SLB-coated MCS a promising release-on-demand system

Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery

Multifunctional mesoporous silica nanoparticles (MSN) have attracted substantial attention with regard to their high potential for targeted drug delivery. For future clinical applications it is crucial to address safety concerns and understand the potential immunotoxicity of these nanoparticles. In this study, we assess the biocompatibility and functionality of multifunctional MSN in freshly isolated, primary murine immune cells. We show that the functionalized silica nanoparticles are rapidly and efficiently taken up into the endosomal compartment by specialized antigen-presenting cells such as dendritic cells. The silica nanoparticles showed a favorable toxicity profile and did not affect the viability of primary immune cells from the spleen in relevant concentrations. Cargo-free MSN induced only very low immune responses in primary cells as determined by surface expression of activation markers and release of pro-inflammatory cytokines such as Interleukin-6, -12 and -1β. In contrast, when surface-functionalized MSN with a pH-responsive polymer capping were loaded with an immune-activating drug, the synthetic Toll-like receptor 7 agonist R848, a strong immune response was provoked. We thus demonstrate that MSN represent an efficient drug delivery vehicle to primary immune cells that is both non-toxic and non-inflammagenic, which is a prerequisite for the use of these particles in biomedical applications

Multifunctional polymer-capped mesoporous silica nanoparticles for pH-responsive targeted drug delivery

Supramolecular templating techniques have been widely used to direct the formation of porous materials with the goal of introducing permanent mesoporosity. While surfactant-directed self-assembly has been exploited for inorganic materials such as titania, silica, organosilica, and zeolites, it has rarely been applied to metal-organic frameworks (MOFs) and coordination polymers. Here we introduce a new family of gemini surfactant-directed zinc imidazolates, referred to as mesostructured imidazolate frameworks (MIFs), and present a detailed study on the influence of different gemini-type surfactants on the formation mechanism and structures of the resulting zinc imidazolates. The proposed formation mechanism for MIF-type materials involves co-assembly and crystallization processes that yield lamellar mesostructured imidazolate frameworks. Understanding and controlling such processes also has implications for the syntheses of microporous zinc imidazolate framework (ZIF) materials, whose formation can be suppressed in surfactant-rich solutions, whereas formation of MIF materials is favored in the presence of surfactants and triggered by the addition of halogenides. Solid-state 2D 13C1H HETCOR NMR measurements on prototypic CTAB-directed MIF-1 establish that the head group moieties of the surfactant molecules interact strongly with the zinc-imidazolate-bromide sheets. Additionally, the NMR analyses suggest that MIF-1 has a significant fraction of surfactant molecules that are interdigitated between the zinc-imidazolate-bromide sheets with an antiparallel stacking arrangement, consistent with the high thermal and chemical stability of the MIF hybrid materials

Multifunctional polymer-capped mesoporous silica nanoparticles for pH-responsive targeted drug delivery

Supramolecular templating techniques have been widely used to direct the formation of porous materials with the goal of introducing permanent mesoporosity. While surfactant-directed self-assembly has been exploited for inorganic materials such as titania, silica, organosilica, and zeolites, it has rarely been applied to metal-organic frameworks (MOFs) and coordination polymers. Here we introduce a new family of gemini surfactant-directed zinc imidazolates, referred to as mesostructured imidazolate frameworks (MIFs), and present a detailed study on the influence of different gemini-type surfactants on the formation mechanism and structures of the resulting zinc imidazolates. The proposed formation mechanism for MIF-type materials involves co-assembly and crystallization processes that yield lamellar mesostructured imidazolate frameworks. Understanding and controlling such processes also has implications for the syntheses of microporous zinc imidazolate framework (ZIF) materials, whose formation can be suppressed in surfactant-rich solutions, whereas formation of MIF materials is favored in the presence of surfactants and triggered by the addition of halogenides. Solid-state 2D 13C1H HETCOR NMR measurements on prototypic CTAB-directed MIF-1 establish that the head group moieties of the surfactant molecules interact strongly with the zinc-imidazolate-bromide sheets. Additionally, the NMR analyses suggest that MIF-1 has a significant fraction of surfactant molecules that are interdigitated between the zinc-imidazolate-bromide sheets with an antiparallel stacking arrangement, consistent with the high thermal and chemical stability of the MIF hybrid materials

Endothelial damage, vascular bagging and remodeling of the microvascular bed in human microangiopathy with deep white matter lesions

White matter lesions (WMLs) are a common manifestation of small vessel disease (SVD) in the elderly population. They are associated with an enhanced risk of developing gait abnormalities, poor executive function, dementia, and stroke with high mortality. Hypoperfusion and the resulting endothelial damage are thought to contribute to the development of WMLs. The focus of the present study was the analysis of the microvascular bed in SVD patients with deep WMLs (DWMLs) by using double- and triple-label immunohistochemistry and immunofluorescence. Simultaneous visualization of collagen IV (COLL4)-positive membranes and the endothelial glycocalyx in thick sections allowed us to identify endothelial recession in different types of string vessels, and two new forms of small vessel/capillary pathology, which we called vascular bagging and ghost string vessels. Vascular bags were pouches and tubes that were attached to vessel walls and were formed by multiple layers of COLL4-positive membranes. Vascular bagging was most severe in the DWMLs of cases with pure SVD (no additional vascular brain injury, VBI). Quantification of vascular bagging, string vessels, and the density/size of CD68-positive cells further showed widespread pathological changes in the frontoparietal and/or temporal white matter in SVD, including pure SVD and SVD with VBI, as well as a significant effect of the covariate age. Plasma protein leakage into vascular bags and the white matter parenchyma pointed to endothelial damage and basement membrane permeability. Hypertrophic IBA1-positive microglial cells and CD68-positive macrophages were found in white matter areas covered with networks of ghost vessels in SVD, suggesting phagocytosis of remnants of string vessels. However, the overall vessel density was not altered in our SVD cohort, which might result from continuous replacement of vessels. Our findings support the view that SVD is a progressive and generalized disease process, in which endothelial damage and vascular bagging drive remodeling of the microvasculature

Mutations of the gene FNIP1 associated with a syndromic autosomal recessive immunodeficiency with cardiomyopathy and pre-excitation syndrome

AMPK (adenosine monophosphate-activated protein kinase) is phosphorylated (AMPK-P) in response to low energy through allosteric activation by Adenosine mono- or diphosphate (AMP/ADP). Folliculin (FLCN) and the FLCN-interacting proteins 1 and 2 (FNIP1, 2) modulate AMPK. FNIP1 deficiency patients have a AMPK-P gain of function phenotype with hypertrophic cardiomyopathy, Wolff-Parkinson-White pre-excitation syndrome, myopathy of skeletal muscles and combined immunodeficiency